Croxford JL - Search Results

1

Invariant V(alpha)19i T cells regulate autoimmune inflammation.

Croxford JL, Miyake S, Huang YY, Shimamura M, Yamamura T. Croxford JL, et al. Nat Immunol. 2006 Sep;7(9):987-94. doi: 10.1038/ni1370. Epub 2006 Jul 30. Nat Immunol. 2006. PMID: 16878136

2

NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora.

Yokote H, Miyake S, Croxford JL, Oki S, Mizusawa H, Yamamura T. Yokote H, et al. Among authors: croxford jl. Am J Pathol. 2008 Dec;173(6):1714-23. doi: 10.2353/ajpath.2008.080622. Epub 2008 Oct 30. Am J Pathol. 2008. PMID: 18974295 Free PMC article.

3

Suppression of experimental autoimmune encephalomyelitis by ghrelin.

Theil MM, Miyake S, Mizuno M, Tomi C, Croxford JL, Hosoda H, Theil J, von Hörsten S, Yokote H, Chiba A, Lin Y, Oki S, Akamizu T, Kangawa K, Yamamura T. Theil MM, et al. Among authors: croxford jl. J Immunol. 2009 Aug 15;183(4):2859-66. doi: 10.4049/jimmunol.0803362. Epub 2009 Jul 20. J Immunol. 2009. PMID: 19620309

4

Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells.

Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, Lutz B, Baker D, Dittel BN. Maresz K, et al. Among authors: croxford jl. Nat Med. 2007 Apr;13(4):492-7. doi: 10.1038/nm1561. Epub 2007 Apr 1. Nat Med. 2007. PMID: 17401376

5

Back to the future for multiple sclerosis therapy: focus on current and emerging disease-modifying therapeutic strategies.

Croxford JL, Yamamura T. Croxford JL, et al. Immunotherapy. 2009 May;1(3):403-23. doi: 10.2217/imt.09.7. Immunotherapy. 2009. PMID: 20635959 Review.

6

Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?

Croxford JL, Yamamura T. Croxford JL, et al. J Neuroimmunol. 2005 Sep;166(1-2):3-18. doi: 10.1016/j.jneuroim.2005.04.023. J Neuroimmunol. 2005. PMID: 16023222 Review.

7

Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.

Croxford JL, Pryce G, Jackson SJ, Ledent C, Giovannoni G, Pertwee RG, Yamamura T, Baker D. Croxford JL, et al. J Neuroimmunol. 2008 Jan;193(1-2):120-9. doi: 10.1016/j.jneuroim.2007.10.024. Epub 2007 Nov 26. J Neuroimmunol. 2008. PMID: 18037503

8

Cannabinoids control spasticity and tremor in a multiple sclerosis model.

Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L. Baker D, et al. Among authors: croxford jl. Nature. 2000 Mar 2;404(6773):84-7. doi: 10.1038/35003583. Nature. 2000. PMID: 10716447

9

Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP139-151 mimic peptide derived from murine hepatitis virus.

Croxford JL, Ercolini AM, Degutes M, Miller SD. Croxford JL, et al. Eur J Immunol. 2006 Oct;36(10):2671-80. doi: 10.1002/eji.200635876. Eur J Immunol. 2006. PMID: 16981179 Free PMC article.

10

Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry.

Croxford JL, Anger HA, Miller SD. Croxford JL, et al. J Immunol. 2005 Jan 15;174(2):907-17. doi: 10.4049/jimmunol.174.2.907. J Immunol. 2005. PMID: 15634913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page